nbf-006
Nucleic acidexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2016 (NCT03641482)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Glutathione S-transferase PiANTISENSE INHIBITOR
GSTP1 antisense inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03819387 | Phase 1 | Mar 18, 2019 | Nitto BioPharma, Inc. |
| NCT03641482 | N/A | Jun 1, 2016 | Bio Nature Essences S.L, Universidad Complutense de Madrid |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bio Nature Essences S.L | For profit | 1 | 0 | 1 | 2016 |
| Nitto BioPharma, Inc. | For profit | 1 | 1 | 1 | 2019 |
| Universidad Complutense de Madrid | Academic/Hospital | 1 | 1 | 1 | 2016 |
3 organizations
Page 1 / 1